SLSónia Lemos

Sónia Lemos

*This is an algorithmically generated author record based on publicly available information.

Sónia Lemos has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Allergy after a sandwich: case report of beer allergy in an adolescent

    by João F. Nico, Vera Mendes, Estefânia Maia, Gina Rubino, Sónia Lemos

    Beer is an uncommon cause of IgE-mediated food allergy despite its widespread consumption. We report an adolescent who developed generalised urticaria and lip angioedema immediately after eating a traditional Portuguese sandwich with a beer-based sauce. He had previously experienced two episodes of delayed generalised urticaria after ingesting small amounts of beer. Serum specific IgE was positive for barley (7.12 kU/l) and barley malt (21.7 kU/l). Prick-to-prick testing was positive for four commercially available beers containing barley malt. He tolerated other barley-containing foods, suggesting that malting and brewing may modify barley proteins and/or generate clinically relevant allergens. The patient was counselled to avoid beer, whisky and foods prepared with barley-malt alcoholic beverages, and was prescribed an adrenaline auto-injector due to the potential risk of anaphylaxis. This case underscores that beer allergy, although rare in paediatrics, should be considered in adolescents presenting with acute urticaria or angioedema after beer consumption or exposure through cooking.

  • Open Access

    Epstein-Barr Virus-negative Diffuse Large B Cell Lymphoma in a X-linked Severe Combined Immunodeficiency Patient: A Very Rare Condition

    by Dina Rochate, Sara Duarte, Rita S. Gomes, Rita Pinho Peixeiro, João Vaz Silva, Ângelo Rodrigues, Luís Leite, Rosa Branca, Sónia Lemos, Joana Guimarães, et al.

    Severe combined immunodeficiency disorders (SCID) are a genetically heterogeneous group of inherited defects characterized by severe abnormalities of immune system development and function that lead to a wide spectrum in clinical manifestations. A subgroup of patients presents a disabling and life-threatening clinical course. In these cases, allogeneic hematopoietic stem cell transplant provides a curative approach. The occurrence of SCID-associated lymphoproliferative disorders is rare and occur mostly in adenosine deaminase-deficient severe combined immunodeficiency disorders, after allogeneic hematopoietic stem cell transplant. Epstein Barr virus infection is present in the majority of individuals with primary immunodeficiency developing lymphoma, revealing compromised anti-tumour surveillance of virally transformed cells. Herein, we report a rare case of diffuse large B cell lymphoma occurring in an Epstein Barr virus negative, non-transplanted X-linked severe combined immunodeficiency 4-months-old infant, successfully treated with immunotherapy and allogeneic stem cell transplantation. This case suggests that Epstein Barr virus -independent mechanism of neoplastic transformation must take action in severe combined immunodeficiency associated lymphoma and unveils the curative potential of donor T cells after allogeneic transplantation.


  • Open Access

    IFNγR1 deficiency presenting with visceral leishmaniasis and Mycobacterium Avium infections mimicking HLH

    by Muhammad Bilal Khalid, Sónia Gaspar Lemos, Katherine Myint-Hpu, Debbie Draper, Jennifer Stoddard, Julie E Niemela, Sergio D Rosenzweig, Stefania Pittaluga, Ottavia M Delmonte, Luigi D Notarangelo


  • Open Access

    Neutropenia in antibody‐deficient patients under IVIG replacement therapy

    by Sonia Lemos, Cristina M. A. Jacob, Antonio C. Pastorino, Ana Paula B. M. Castro, Ângela B. F. Fomin, Magda M. S. Carneiro‐Sampaio

    Patients with antibody deficiencies are more prone to develop acute neutropenic episodes even during immunoglobulin replacement. The aims of this study were to evaluate the presence of acute neutropenia in 42 patients with primary antibody immunodeficiencies, currently receiving intravenous immunoglobulin (IVIG), and to describe the clinical and laboratory findings during neutropenic episodes. Of all patients, 10 (23.8%) presented acute neutropenia (absolute neutrophil count 3) during follow up (mean of 6.4 yr). The absolute neutrophil count ranged from 71 to 1488 cells/mm3. Neutropenia was not clearly associated with antibiotic prophylactic therapy or immunoglobulin levels, while infections were associated with neutropenia in the majority of episodes. Most acute neutropenia episodes were mild or moderate, except in CVID patients who present more severe neutropenia. Although IVIG may have contributed to reducing the severity of neutropenia, it does not prevent its occurrence in all patients. In conclusion, primary immunodeficient patients, even submitted to IVIG replacement therapy, must be regularly evaluated for neutropenia in order to minimize the risk of infections and its appropriate approach.